Accès gratuit
Numéro
Med Sci (Paris)
Volume 30, Numéro 12, Décembre 2014
Page(s) 1136 - 1143
Section M/S Revues
DOI https://doi.org/10.1051/medsci/20143012017
Publié en ligne 24 décembre 2014
  1. Schenck CH, Bassetti CL, Arnulf I, Mignot E. English translations of the first clinical reports on narcolepsy and cataplexy by Westphal and Gélineau in the late 19th century, with commentary. J Clin Sleep Med 2007 ; 3 : 301–1. [PubMed]
  2. Gélineau JB. De la narcolepsie. Gazette des Hôpitaux Civils et Militaires 1880 ; 53 : 626–8 et 1881; 54 : 635-7.
  3. Billiard M. Narcolepsy. Clinical features and aetiology. Ann Clin Res 1985 ; 17 : 220–6. [PubMed]
  4. Parkes JD, Fenton G, Struthers G, et al. Record C: narcolepsy and cataplexy. Clinical features, treatment and cerebrospinal fluid findings. QJM 1974 ; 43 : 525–36.
  5. Murray TJ, Foley A. Narcolepsy. Can Med Assoc J 1974 ; 110 : 63–6. [PubMed]
  6. Dauvilliers Y, Arnulf I, Mignot E. Narcolepsy with cataplexy. Lancet 2007 ; 369 : 499–511. [CrossRef] [PubMed]
  7. Okun ML, Lin L, Pelin Z, et al. Clinical aspects of narcolepsy-cataplexy across ethnic groups. Sleep 2002 ; 25 : 27–35. [PubMed]
  8. International Classification of Sleep Disorders, third edition (ICSD-3). American Academy of Sleep Medicine, 2014. http://www.aasmnet.org
  9. DSM-5 Development. In : DSM-5. The future of psychiatric diagnosis. American Psychiatric Association, 2013.
  10. Mahlios J, De la Herrán-Arita AK, Mignot E. The autoimmune basis of narcolepsy. Curr Opin Neurobiol 2013 ; 23 : 767–73. [CrossRef] [PubMed]
  11. Honda Y.. Census of narcolepsy, cataplexy, sleep life among teenagers in Fujisawa city. Sleep Res 1979 ; 8 : 191.
  12. Tashiro T, Kanbayashi T, Hishikawa Y.. An epidemiological study on prevalence of narcolepsy in Japanese. Sleep Res 1992 ; 1 (suppl) : 228.
  13. Lavie P, Peled R. Narcolepsy is a rare disease in Israel. Sleep 1987 ; 10 : 608–9. [PubMed]
  14. Wise MS. Childhood narcolepsy. Neurology 1998 ; 50 : S37–42. [CrossRef] [PubMed]
  15. Mignot E. Genetic and familial aspects of narcolepsy. Neurology 1998 ; 50 : S16–22. [CrossRef] [PubMed]
  16. Overeem S, Black JL, Lammers GJ. Narcolepsy: immunological aspects. Sleep Med Rev 2008 ; 12 : 95–107. [CrossRef] [PubMed]
  17. Pizza F, Franceschini C, Peltola H, et al. Clinical and polysomnographic course of childhood narcolepsy with cataplexy. Brain J Neurol 2013 ; 136 : 3787–95. [CrossRef]
  18. Lin L, Faraco J, Li R, et al. The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell 1999 ; 98 : 365–76. [CrossRef]
  19. Chemelli RM, Willie JT, Sinton CM, et al. Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell 1999 ; 98 : 437–51. [CrossRef] [PubMed]
  20. Tsujino N, Sakurai T. Orexin/hypocretin: A neuropeptide at the interface of sleep, energy homeostasis, and reward system. Pharmacol Rev 2009 ; 61 : 162–76. [CrossRef] [PubMed]
  21. Nishino S, Takeshi S (eds). The orexin/hypocretin system, Physiology and pathophysiology, Humana press, 2005 : 416 p.
  22. Heier MS, Jansson TS, Gautvik KM. Cerebrospinal fluid hypocretin 1 deficiency, overweight, and metabolic dysregulation in patients with narcolepsy. J Clin Sleep Med 2011 , 7 : 653–8. [PubMed]
  23. Andlauer O, Moore H, Hong SC, et al. Predictors of hypocretin (orexin) deficiency in narcolepsy without cataplexy. Sleep 2012 ; 35 : 1247–55. [PubMed]
  24. Mignot E, Hayduk R, Black J, et al. HLA DQB1*0602 is associated with cataplexy in 509 narcoleptic patients. Sleep 1997 ; 20 : 1012–20. [PubMed]
  25. Tafti M, Hor H, Dauvilliers Y, et al. DQB1 locus alone explains most of the risk and protection in narcolepsy with cataplexy in Europe. Sleep 2014 ; 37 : 19–25. [PubMed]
  26. Honda Y, Juji T (eds). HLA in narcolepsy, Springer, 1988 : 210 p.
  27. Juji T, Satake M, Honda Y, Doi Y. HLA antigens in Japanese patients with narcolepsy. All the patients were DR2 positive. Tissue Antigens 1984 ; 24 : 316–9. [CrossRef] [PubMed]
  28. Hallmayer J. Narcolepsy is strongly associated with the T-cell receptor alpha locus. Nat Genet 2009 ; 41 : 708–11. [CrossRef] [PubMed]
  29. Faraco J, Lin L, Kornum BR, et al. ImmunoChip study implicates antigen presentation to T cells in narcolepsy. PLoS Genet 2013 ; 9 : e1003270. [CrossRef] [PubMed]
  30. Han F, Faraco J, Dong XS, et al. Genome wide analysis of narcolepsy in China implicates novel immune loci and reveals changes in association prior to versus after the 2009 H1N1 influenza pandemic. PLoS Genet 2013 ; 9 : e1003880. [CrossRef] [PubMed]
  31. Winkelmann J, Lin L, Schormair B, et al. Mutations in DNMT1 cause autosomal dominant cerebellar ataxia, deafness and narcolepsy. Hum Mol Genet 2012 ; 21 : 2205–10. [CrossRef] [PubMed]
  32. Han F, Lin L, Warby SC, et al. Narcolepsy onset is seasonal and increased following the 2009 H1N1 pandemic in china. Ann Neurol 2011 ; 70 : 410–7. [CrossRef] [PubMed]
  33. Han F, Lin L, Li J, et al. Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic. Ann Neurol 2013 ; 73 : 560. [CrossRef] [PubMed]
  34. Vincent A. Encephalitis lethargica: part of a spectrum of post-streptococcal autoimmune diseases? Brain J Neurol 2004 ; 127 : 2–3. [CrossRef]
  35. Lehmann HC, Hartung HP, Kieseier BC, Hughes RAC. Guillain-Barré syndrome after exposure to influenza virus. Lancet Infect Dis 2010 ; 10 : 643–51. [CrossRef] [PubMed]
  36. Dauvilliers Y, Arnulf I, Lecendreux M, et al. Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France. Brain J Neurol 2013 ; 136 : 2486–96. [CrossRef]
  37. Han F, Lin L, Li J, et al. Presentations of primary hypersomnia in Chinese children. Sleep 2011 ; 34 : 627–32. [PubMed]
  38. Aran A, Lin L, Nevsimalova S, et al. Elevated anti-streptococcal antibodies in patients with recent narcolepsy onset. Sleep 2009 ; 32 : 979–83. [PubMed]
  39. Wijnans L, Lecomte C, de Vries C, et al. The incidence of narcolepsy in Europe: before, during, and after the influenza A(H1N1)pdm09 pandemic and vaccination campaigns. Vaccine 2013 ; 31 : 1246–54. [CrossRef] [PubMed]
  40. Partinen M, Kornum BR, Plazzi G, et al. Narcolepsy as an autoimmune disease: the role of H1N1 infection and vaccination. Lancet Neurol 2014 ; 13 : 600–13. [CrossRef] [PubMed]
  41. Ahmed SS, Schur PH, Macdonald NE, Steinman L. Narcolepsy, 2009 A(H1N1) pandemic influenza, and pandemic influenza vaccinations: what is known and unknown about the neurological disorder, the role for autoimmunity, and vaccine adjuvants. J Autoimmun 2014 ; 50C : 1–11. [CrossRef]
  42. Nohynek H, Jokinen J, Partinen M, et al. AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland. PloS One 2012 ; 7 : e33536. [CrossRef] [PubMed]
  43. Partinen M, Saarenpaa-Heikkila O, Ilveskoski I, et al. Increased incidence and clinical picture of childhood narcolepsy following the 2009 H1N1 pandemic vaccination campaign in Finland. PLoS One 2012 ; 7 : e33723. [CrossRef] [PubMed]
  44. O’Flanagan D, Barret AS, Foley M, et al. Investigation of an association between onset of narcolepsy and vaccination with pandemic influenza vaccine, Ireland, April 2009-December 2010. Euro Surveill 2014 ; 19 : 15–25. [PubMed]
  45. Dauvilliers Y, Montplaisir J, Cochen V, et al. Post-H1N1 narcolepsy-cataplexy. Sleep 2010 ; 33 : 1428–30. [PubMed]
  46. Winstone AM, Stellitano L, Verity C, et al. Clinical features of narcolepsy in children vaccinated with AS03 adjuvanted pandemic A/H1N1 2009 influenza vaccine in England. Dev Med Child Neurol 2014 ; doi : 10.1111/dmcn.12522
  47. Mendes MFSG, de Campos Valladares Neto D, de Azevedo RA, Caramelli P. Narcolepsy after A/H1N1 vaccination. Clinics 2012 ; 67 : 77–8. [CrossRef]
  48. Montplaisir J, Petit D, Quinn MJ, et al. Risk of narcolepsy associated with inactivated adjuvanted (AS03) A/H1N1 (2009) pandemic influenza vaccine in Quebec. PloS One 2014 ; 9 : e108489. [CrossRef] [PubMed]
  49. Duffy J, Weintraub E, Vellozzi C, DeStefano F. on behalf of the vaccine safety datalink. Narcolepsy and influenza A(H1N1) pandemic 2009 vaccination in the United States. Neurology 2014 ; doi : 10.1212/WNL.0000000000000987
  50. Nicolson C, Harvey R, Johnson R, et al. An additional oligosaccharide moiety in the HA of a pandemic influenza H1N1 candidate vaccine virus confers increased antigen yield in eggs. Vaccine 2012 ; 30 : 745–51. [CrossRef] [PubMed]
  51. Robertson JS, Nicolson C, Harvey R, et al. The development of vaccine viruses against pandemic A(H1N1) influenza. Vaccine 2011 ; 29 : 1836–43. [CrossRef] [PubMed]
  52. Leroux-Roels I, Roman F, Forgus S, et al. Priming with AS03 A-adjuvanted H5N1 influenza vaccine improves the kinetics, magnitude and durability of the immune response after a heterologous booster vaccination: an open non-randomised extension of a double-blind randomised primary study. Vaccine 2010 ; 28 : 849–57. [CrossRef] [PubMed]
  53. Kornum BR, Kawashima M, Faraco J, et al. Common variants in P2RY11 are associated with narcolepsy. Nat Genet 2011 ; 43 : 66–71. [CrossRef] [PubMed]
  54. Bergman P, Adori C, Vas S, et al. Narcolepsy patients have antibodies that stain distinct cell populations in rat brain and influence sleep patterns. Proc Natl Acad Sci USA 2014 ; 111 : E3735–44. [CrossRef]
  55. Dauvilliers Y, Jaussent I, Lecendreux M, et al. Cerebrospinal fluid and serum cytokine profiles in narcolepsy with cataplexy: a case-control study. Brain Behav Immun 2014 ; 37 : 260–6. [CrossRef] [PubMed]

Les statistiques affichées correspondent au cumul d'une part des vues des résumés de l'article et d'autre part des vues et téléchargements de l'article plein-texte (PDF, Full-HTML, ePub... selon les formats disponibles) sur la platefome Vision4Press.

Les statistiques sont disponibles avec un délai de 48 à 96 heures et sont mises à jour quotidiennement en semaine.

Le chargement des statistiques peut être long.